000 | 01426na a2200385 4500 | ||
---|---|---|---|
999 |
_c525 _d525 |
||
003 | PC525 | ||
005 | 20210614111341.0 | ||
008 | 130622s2013 xxx||||| |||| 00| 0 eng d | ||
040 | _cH12O | ||
041 | _aeng | ||
100 |
_aMérida Herrero, Evangelina _92030 _eNefrología |
||
100 |
_aPraga Terente, Manuel _91488 _eNefrología |
||
245 | 0 | 0 |
_aMycophenolate as Maintenance Therapy for Lupus Nephritis with Impaired Renal Function _h[artículo] |
260 |
_bAmerican Journal of Nephrology, _c2013 |
||
300 | _a 37(6):509-17. | ||
500 | _aFormato Vancouver: Rivera F, Illescas ML, López-Rubio E, Fulladosa J, Poveda R, Baltar J et al. Mycophenolate as maintenance therapy for lupus nephritis with impaired renal function. Am J Nephrol. 2013;37(6):509-17. | ||
501 | _aPMID: 23689615 | ||
504 | _aContiene 33 referencias | ||
520 | _aBackground: Mycophenolate (MF) is effective as a maintenance therapy after induction therapy in patients with lupus nephritis (LN). However, little is known about its role in patients with impaired renal function. The purpose of this study was to evaluate the efficacy and safety of ME as a maintenance therapy for LN and its association with renal function. Methods: Data were obtained for 56 Spanish patients who were receiving | ||
710 |
_986 _aServicio de Nefrología |
||
856 |
_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/5/pc525.pdf _ySolicitar documento |
||
942 |
_n0 _2ddc _cART |